Between July 2023 - when Intuitive first mentioned weight loss drugs - and October 2023, medical device companies that were deemed GLP-1 losers sold off aggressively (e.g., diabetes medical devices, sleep apnea devices, bariatric surgery), while the GLP-1 companies themselves (Eli Lilly and Novo Nordisk) increased in value much more than the broader market
The roles of NRF2 in modulating cellular iron homeostasis
We have included the most complete and latest available GLP-1RAs, and several novel drugs were pooled and compared in a network meta-analysis for the first time
Evidence and UK Guidance GLP-1 receptor agonists have gained considerable attention for their role in weight management, prompting questions about their effects on abdominal fat
SUSTAIN-6 specifically looked at cardiovascular outcomes including renal endpoints
More than 95% of the body's L-carnitine stores are found in skeletal muscle (muscle which is connected to your skeleton), along with trace amounts in the liver and blood